Functional role of arginine 375 in transmembrane helix 6 of multidrug resistance protein 4 (MRP4/ABCC4)

Molecular Pharmacology

Volumn 74, Issue 4, 2008, Pages 964-971

  El Sheikh, Azza A K ^a   Van Den Heuvel, Jeroen J M W ^a   Krieger, Elmar ^a   Russel, Frans G M ^a   Koenderink, Jan B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGININE; CYCLIC GMP; GLUTAMINE; LYSINE; METHOTREXATE; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 4; PHENYLALANINE;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING SITE; CELL MEMBRANE; HUMAN; HUMAN CELL; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE;

5'-GUANYLIC ACID; ALANINE; AMINO ACID SUBSTITUTION; ARGININE; BACULOVIRIDAE; BINDING SITES; BIOLOGICAL TRANSPORT; CELL LINE; CELL MEMBRANE; CELLULAR STRUCTURES; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; KIDNEY; KINETICS; METHOTREXATE; MODELS, MOLECULAR; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY;

EID: 52949106057     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.043661     Document Type: Article

References (39)

1. Borst P, de Wolf C, and van de Wetering K (2007) Multidrug resistance-associated proteins 3, 4, and 5. Pflugers Arch 453:661-673.
2. Canutescu AA, Shelenkov AA, and Dunbrack RL Jr (2003) A graph-theory algorithm for rapid protein side-chain prediction. Protein Sci 12:2001-2014.
3. Chen C and Klaassen CD (2004) Rat multidrug resistance protein 4 (Mrp4, Abcc4): molecular cloning, organ distribution, postnatal renal expression, and chemical inducibility. Biochem Biophys Res Commun 317:46-53.
4. Chen ZS, Lee K, Walther S, Raftogianis RB, Kuwano M, Zeng H, and Kruh GD (2002) Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system. Cancer Res 62:3144-3150.
5. Daoud R, Julien M, Gros P, and Georges E (2001) Major photoaffinity drug binding sites in multidrug resistance protein 1 (MRP1) are within transmembrane domains 10-11 and 16-17. J Biol Chem 276:12324-12330.
6. Dawson RJ and Locher KP (2006) Structure of a bacterial multidrug ABC transporter. Nature 443:180-185.
7. Deeley RG, Westlake C, and Cole SP (2006) Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol Rev 86:849-899.
8. Ecker GF, Pleban K, Kopp S, Csaszar E, Poelarends GJ, Putman M, Kaiser D, Konings WN, and Chiba P (2004) A three-dimensional model for the substrate binding domain of the multidrug ATP binding cassette transporter LmrA. Mol Pharmacol 66:1169-1179.
9. El-Sheikh AA, van den Heuvel JJ, Koenderink JB, and Russel FG (2007) Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2/A. J Pharmacol Exp Ther 320:229-235.
10. Hooft RW, Vriend G, Sander C, and Abola EE (1996) Errors in protein structures. Nature 381:272.
11. Ito K, Oleschuk CJ, Westlake C, Vasa MZ, Deeley RG, and Cole SP (2001a) Mutation of Trp1254 in the multispecific organic anion transporter, multidrug resistance protein 2 (MRP2) (ABCC2), alters substrate specificity and results in loss of methotrexate transport activity. J Biol Chem 276:38108-38114.
12. Ito K, Olsen SL, Qiu W, Deeley RG, and Cole SP (2001b) Mutation of a single conserved tryptophan in multidrug resistance protein 1 (MRP1/ABCC1) results in loss of drug resistance and selective loss of organic anion transport. J Biol Chem 276:15616-15624.
13. Koike K, Conseil G, Leslie EM, Deeley RG, and Cole SP (2004) Identification of proline residues in the core cytoplasmic and transmembrane regions of multidrug resistance protein 1 (MRP1/ABCC1) important for transport function, substrate specificity, and nucleotide interactions. J Biol Chem 279:12325-12336.
14. Konagurthu AS, Whisstock JC, Stuckey PJ, and Lesk AM (2006) MUSTANG: a multiple structural alignment algorithm. Proteins 64:559-574.
15. Krieger E, Darden T, Nabuurs SB, Finkelstein A, and Vriend G (2004) Making optimal use of empirical energy functions: force-field parameterization in crystal space. Proteins 57:678-683.
16. Krieger E, Koraimann G, and Vriend G (2002) Increasing the precision of comparative models with YASARA NOVA-a self-parameterizing force field. Proteins 47:393-402.
17. Krieger E, Nielsen JE, Spronk CA, and Vriend G (2006) Fast empirical PKa prediction by Ewald summation. J Mol Graph Model 25:481-486.
18. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
19. Leslie EM, Ito K, Upadhyaya P, Hecht SS, Deeley RG, and Cole SP (2001) Transport of the β-O-glucuronide conjugate of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1). Requirement for glutathione or a non-sulfur-containing analog. J Biol Chem 276:27846-27854.
20. Loo TW, Bartlett MC, and Clarke DM (2007) Nucleotide binding, ATP hydrolysis, and mutation of the catalytic carboxylates of human p-glycoprotein cause distinct conformational changes in the transmembrane segments. Biochemistry 46:9328-9336.
21. Martin C, Berridge G, Higgins CF, Mistry P, Charlton P, and Callaghan R (2000) Communication between multiple drug binding sites on P-glycoprotein. Mol Pharmacol 58:624-632.
22. Notredame C, Higgins DG, and Heringa J (2000) T-Coffee: a novel method for fast and accurate multiple sequence alignment. J Mol Biol 302:205-217.
23. Quint A, Lerer I, Sagi M, and Abeliovich D (2005) Mutation spectrum in Jewish cystic fibrosis patients in Israel: implication to carrier screening. Am J Med Genet A 136:246-248.
24. Ramaen O, Leulliot N, Sizun C, Ulryck N, Pamlard O, Lallemand JY, Tilbeurgh H, and Jacquet E (2006) Structure of the human multidrug resistance protein 1 nucleotide binding domain 1 bound to Mg2+/ATP reveals a non-productive catalytic site. J Mol Biol 359:940-949.
25. Ren XQ, Furukawa T, Aoki S, Sumizawa T, Haraguchi M, Nakajima Y, Ikeda R, Kobayashi M, and Akiyama S (2002) A positively charged amino acid proximal to the C-terminus of TM17 of MRP1 is indispensable for GSH-dependent binding of substrates and for transport of LTC4. Biochemistry 41:14132-14140.
26. Russel FG, Koenderink JB, and Masereeuw R (2008) Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules. Trends Pharmacol Sci 29:200-207.
27. Ryu S, Kawabe T, Nada S, and Yamaguchi A (2000) Identification of basic residues involved in drug export function of human multidrug resistance-associated protein 2. J Biol Chem 275:39617-39624.
28. Schäfer HJ, Coskun U, Eger O, Godovac-Zimmermann J, Wieczorek H, Kagawa Y, and Grüber G (2001) 8-N(3)-3′-Biotinyl-ATP, a novel monofunctional reagent: differences in the F(1)- and V(1)-ATPases by means of the ATP analogue. Biochem Biophys Res Commun 286:1218-1227.
29. Schuetz JD, Connelly MC, Sun D, Paibir SG, Flynn PM, Srinivas RV, Kumar A, and Fridland A (1999) MRP4: a previously unidentified factor in resistance to nucleoside-based antiviral drugs. Nat Med 5:1048-1051.
30. van Aubel RA, Smeets PH, Peters JG, Bindels RJ, and Russel FG (2002) The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary CAMP and CGMP. J Am Soc Nephrol 13:595-603.
31. Van Aubel RA, Smeets PH, van den Heuvel JJ, and Russel FG (2005) Human organic anion transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate with multiple allosteric substrate binding sites. Am J Physiol Renal Physiol 288:F327-F333.
32. van de Water FM, Masereeuw R, and Russel FG (2005) Function and regulation of multidrug resistance proteins (MRPs) in the renal elimination of organic anions. Drug Metab Rev 37:443-471.
33. Wielinga PR, Reid G, Challa EE, van der Heijden I, van Deemter L, de Haas M, Mol C, Kuil AJ, Groeneveld E, Schuetz JD, et al. (2002) Thiopurine metabolism and identification of the thiopurine metabolites transported by MRP4 and MRP5 overexpressed in human embryonic kidney cells. Mol Pharmacol 62:1321-1331.
34. Zelcer N, Huisman MT, Reid G, Wielinga P, Breedveld P, Kuil A, Knipscheer P, Schellens JH, Schinkel AH, and Borst P (2003) Evidence for two interacting ligand binding sites in human multidrug resistance protein 2 (ATP binding cassette C2). J Biol Chem 278:23538-23544.
35. Zhang DW, Cole SP, and Deeley RG (2001) Identification of a nonconserved amino acid residue in multidrug resistance protein 1 important for determining substrate specificity: evidence for functional interaction between transmembrane helices 14 and 17. J Biol Chem 276:34966-34974.
36. Zhang DW, Gu HM, Situ D, Haimeur A, Cole SP, and Deeley RG (2003a) Functional importance of polar and charged amino acid residues in transmembrane helix 14 of multidrug resistance protein 1 (MRP1/ABCC1): identification of an aspartate residue critical for conversion from a high to low affinity substrate binding state. J Biol Chem 278:46052-46063.
37. Zhang DW, Gu HM, Vasa M, Muredda M, Cole SP, and Deeley RG (2003b) Characterization of the role of polar amino acid residues within predicted transmembrane helix 17 in determining the substrate specificity of multidrug resistance protein 3. Biochemistry 42:9989-10000.
38. Zhang DW, Nunoya K, Vasa M, Gu HM, Cole SP, and Deeley RG (2006) Mutational analysis of polar amino acid residues within predicted transmembrane helices 10 and 16 of multidrug resistance protein 1 (ABCC1): effect on substrate specificity. Drug Metab Dispos 34:539-546.
39. Zhang DW, Nunoya K, Vasa M, Gu HM, Theis A, Cole SP, and Deeley RG (2004) Transmembrane helix 11 of multidrug resistance protein 1 (MRP1/ABCC1): identification of polar amino acids important for substrate specificity and binding of ATP at nucleotide binding domain 1. Biochemistry 43:9413-9425.